Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh)
Bansisons Tea Industries Ltd · Outcome · 14 Aug 2026, 11:37 pm
Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) ■ Revenue: 173 (+1553.4% QoQ) ■ EBITDA: -1.7 (+44.6% YoY | +99.7% QoQ) ■ EBITDA Margin (%): -1.0 (+510534 bps QoQ) ■ PAT: -2.0 (-158.4% YoY | +99.6% QoQ) ■ EPS (INR): -0.03 (-200.0% YoY | +99.6% QoQ) Bansisons Tea Industries Ltd - Financial Result for the Quarter ended 30th Jun'26 (Standalone, INR Lakh) Segmental Performance Pharma ■ Revenue: 173 (+17161.0% QoQ) ■ EBIT: 1.3 (+29.0% QoQ) ■ EBIT Margin (%): 0.7 (-9925 bps QoQ) Real Estate ■ Revenue: 0.0 (-100.0% QoQ) ■ EBIT: 0.0 (-100.0% QoQ) ■ EBIT Margin (%): 0.0 (-10000 bps QoQ) Tea Estate ■ Revenue: 0.0 (-100.0% QoQ) ■ EBIT: 0.0 (Loss to Profit QoQ) ■ EBIT Margin (%): 0.0 (Loss to Profit QoQ)
Original exchange filing (PDF)
More announcements from Bansisons Tea Industries Ltd
- Unaudited Financial Results for the quarter ended September 30, 2026 · 02 Nov 2026
- Unaudited financial results for the quarter ended September 30, 2026 · 02 Nov 2026
- Novyra Pharmachem Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/11/2026 ,inter alia, to consider and approve Un-Audited Financial Results .... · 02 Nov 2026
- Intimation under Reg 30 · 24 Sept 2026
- Reg 30 · 22 Aug 2026
- Quarterly Results June 30, 2026 · 14 Aug 2026
- Bansisons Tea Industries Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Quarterly Results June 30, 2026 · 14 Aug 2026
- Change of Website · 04 Aug 2026
